WaferGen Plans Europe HQ in Luxembourg | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomarker discovery company WaferGen plans to open a European headquarters in Luxembourg, the company said today.

The new facility in central Europe would include sales and marketing, service and support, distribution, some research and development, and management of distributors and subsidiaries, the Freemont, Calif.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.